BNTX - BioNTech SE

85.68
-1.780   -2.077%

Share volume: 706,303
Last Updated: 03-27-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$87.46
-1.78
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024
Fiscal Quarter Q1 2024
Report Date 05-06-2024
Total revenue 202.610 M
Cost of revenue 63.829 M
Gross profit 138.781 M
     
Operating expenses 691.315 M
Selling general and admin 143.209 M
Research and development 548.105 M
Total expenses 755.143 M
     
Operating income -552.533 M
Ebit -552.533 M
Pretax income -358.347 M
     
Income tax -18.036 M
Net income basic -340.311 M
     
Net income -340.311 M